有五项来自南亚的试验符合入选标准。
Five trials, all from south Asia, satisfied the inclusion criteria.
他们确定了研究入选标准。
按照入选标准，有7项随机对照实验纳入本研究。
According to the inclusion criteria, 7 studies were selected.
按照入选标准，有18项随机对照实验纳入本研究。
According to the inclusion criteria, 18 studies were selected.
最主要的入选标准是以缺血性卒中为基本诊断而收治者。
The major inclusion criterion was admission to an acute carefacility with a principal diagnosis of ischemic stroke.
结果：33个试验评价了符合入选标准的1367名患者。
Results: Thirty-three trials evaluating 1367 patients fulfilled inclusion criteria.
入选标准为既往无急、慢性腕关节疾病及腕部和前臂骨折病史。
They had no previous history of acute or chronic disease of the wrist and no wrist or forearm fracture history.
自7880项电子数据资料库搜索而符合入选标准的有两份研究。
Two studies of the 7880 identified from searching the electronic databases met the inclusion criteria.
来自11个国家的17项研究满足入选标准，包括了13923对母亲和儿童。
Seventeen studies including a total of 13 923 mother and child pairs from 11 countries met inclusion criteria.
为了回答这个问题，我们记录了已纳入的研究文献内的患者入选标准。
To address this question, we recorded the patient enrollment criteria of the included studies.
方法将80例符合入选标准的乳腺癌患者，随机分为治疗组和对照组。
Method: 80 breast cancer patients matched with the inclusion criteria were allocated randomly into two groups.
方法将64例符合入选标准的乳腺癌患者，随机分为治疗组和对照组。
Method 64 breast cancer patients matched with the inclusion criteria were allocated randomly into two groups.
方法：将符合病例入选标准的116例患者随机分为治疗组、对照组各58例。
Method: The inclusion criteria found 116 cases. The patients were randomly divided into two groups:control group and treatment group(58 cases, each).
在这个试验中，入选标准为年龄大于45岁经历保乳手术的浸润性导管癌的患者。
In this trial, women aged at least 45 years with invasive ductal breast carcinoma undergoing breast-conserving surgery were enrolled.
结果：符合入选标准的患者有136例，40例患者院内发生心功能不全，占29.4%。
RESULTS: 136 patients met the entry criteria. Heart failure occurred to 40 patients (29.4%).
115篇文章满足入选标准(98份个案报告和17份病例分析)，共计报告了479例针灸后不良事件。
The inclusion criteria were met by 115 articles (98 case reports and 17 case series) that in total reported on 479 cases of adverse events after acupuncture.
方法：采用随机对照的实验设计，符合入选标准的40例中、重度泌尿系感染病人进入本研究。
Methods: in a prospective, randomized and controlled trial, 40 patients with acute severe urinary tract infections were divided into two groups.
结果按照严格的入选标准和排除标准共选出患者117人，其中有男性患者71人，女性患者46人。
RESULTS 117 patients were selected with strict inclusion criteria and exclusion criteria, including 71 male patients, 46 female patients.
根据射频与射频联合全身化疗的随机分组方案入选标准，射频组12例，射频联合全身化疗组15例。
Through a prospective randomized trial, 12 patients were in the RFA group and 15 patients in the RFA combined with systemic chemotherapy group.
方法将符合入选标准的48例双硫仑样反应患者随机分为清开灵组（治疗组）和能量补液组（对照组）；
Methods 48 disulfiram-like reaction cases were randomly divided into the treatment group(Qingkailing group)and the control group(energy fluid replacement group).
方法：采用前瞻、随机和对照的设计方案，符合入选标准的40例中、重度泌尿系统感染患者纳入本研究。
Methods: The prospective, randomized, and controlled study was conducted in 40 patients wi th acute severe urinary tract infections.
方法选择2000年12月至2004年11月，所有经肺螺旋CT证实为急性肺栓塞，并且符合入选标准的40例住院患者。
Methods Analysis of ECG changes in 40 Chinese patients who were diagnosed with APE by spiral CT angiography was made during 12/2000-11/2004.
ICCA的入选标准为：3～20个月出现良性婴儿惊厥（BFIC）和在儿童后期或青春期出现发作性运动源性运动障碍（PKC）。
ICCA was defined as consisting of benign familial infantile convulsion (BFIC) in 3~20 months after birth and PKC occurring in later childhood or adolescence.
结果在符合入选标准的58例脑梗死患者中，经西部失语成套测验评定12例为运动性失语、21例为感觉性失语，其他失语症类型25例。
Results Total 58 patients were enrolled in our study in which there were 12 Broca's aphasia cases, 21 Wernicke's aphasia cases and 25 other aphasia types cases.
方法：选择符合入选标准的高血压患者336例，采用聚合酶链反应-限制性片段长度多态性（PCR-RFLP）的方法，进行ACE2基因分型。
Methods:336 hypertension patients were recruited in this trail. The distribution of ACE2 gene A9570G polymorphism was analyzed by PCR-RFLP in all participants.
19篇文章满足入选合格标准，其中仅有2篇文章满足高质量标准。
The eligibility criteria for inclusion in the review were met by 19 articles, only 2 of which met the criterion of high quality.
选择标准：比较对照和钙通道阻断剂围移植手术期给药的随机对照试验入选。半随机对照试验被排除。
SELECTION CRITERIA: Randomised controlled trials comparing calcium channel blockers given in the peri-transplant period with controls were included. Quasi-randomised trials were excluded.
有一半入选者是基于医生对于其不适于维生素K拮抗剂治疗的判断而入选，并没有所谓严格的“不适宜”标准被使用。
Half were enrolled on the basis of a physician's judgment that a vitamin K antagonist was inappropriate for the patient; no strict case definition for "unsuitable" was used.
年龄方面的标准，没有研究入选了小于18岁或骨骼未成熟的患者。
In studies with age criteria, no studies enrolled patients under the age of 18 years or not of skeletal maturity.
年龄方面的标准，没有研究入选了小于18岁或骨骼未成熟的患者。
In studies with age criteria, no studies enrolled patients under the age of 18 years or not of skeletal maturity.
应用推荐